Literature DB >> 32308106

MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.

Anmin You1, Liwu Fu1, Yongjiao Li1, Xingyi Li1, Bin You1.   

Abstract

MicroRNAs (miRNAs) have been reported to serve pivotal roles in the regulation of papillary thyroid cancer (PTC) development; thus, the aim of this study is to identify the impact of miR-203 and AKT3 on the epithelial-mesenchymal transition (EMT), migration and invasion of PTC. MiR-203 and AKT3 expression in PTC tissues and cells were tested. TPC-1 cells and K1 cells were screened for follow-up experiments. Apoptosis-related proteins (Bcl-2 and Bax), EMT-related proteins (Vimentin and E-cadherin), proliferation-associated proteins (Ki67 and CDK4), invasion- and migration-related protein (MMP-2 and MMP-9) were verified. The effects of upregulated miR-203 and downregulated AKT3 on the biological characteristics of PTC cells in each group were detected via the gain- and loss-of-function assays. The targeting relationship between miR-203 and AKT3 was verified.MiR-203 expression declined and AKT3 heightened in PTC tissues and cells. Upregulated miR-203 and downregulated AKT3 reduced the tumor volume and weight, suppressed cell migration, colony formation, proliferation, invasion, proliferation-associated proteins (Ki67 and CDK4), invasion- and migration-related protein (MMP-2 and MMP-9) and promoted cell apoptosis, raised E-cadherin and decreased Vimentin protein expression in TPC-1 cells. On the contrary, the K1 cells with the downregulated miR-203 or upregulated AKT3 exhibited an opposite result. This study suggests that upregulated miR-203 suppresses EMT, invasion, proliferation and migration as well as induces apoptosis of PTC cells via downregulated AKT3.

Entities:  

Keywords:  AKT; MicroRNA-203; epithelial–mesenchymal transition; invasion; migration; papillary thyroid cancer

Mesh:

Substances:

Year:  2020        PMID: 32308106      PMCID: PMC7217351          DOI: 10.1080/15384101.2020.1746490

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

1.  miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Authors:  Rui Li; Jia Liu; Qun Li; Guang Chen; Xiaofang Yu
Journal:  Tumour Biol       Date:  2015-10-19

2.  LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.

Authors:  Meihua Liang; Jinliang Jia; Lili Chen; Biyue Wei; Qiang Guan; Zhaoming Ding; Jiawei Yu; Rui Pang; Guoqing He
Journal:  Endocrine       Date:  2019-04-27       Impact factor: 3.633

3.  MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

Authors:  Guo-Qing Sui; Dan Fei; Feng Guo; Xi Zhen; Qiang Luo; Shuai Yin; Hui Wang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

4.  MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.

Authors:  Ping Zhou; Nan Jiang; Guo-Xia Zhang; Qing Sun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-08-18       Impact factor: 3.848

5.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

6.  A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.

Authors:  Kenneth K W To; Wing W Leung; Simon S M Ng
Journal:  Mol Carcinog       Date:  2016-06-10       Impact factor: 4.784

7.  miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.

Authors:  Yongbin Chi; Qinqin Jin; Xinghui Liu; Limin Xu; Xiaoxue He; Yan Shen; Qiang Zhou; Jue Zhang; Mingming Jin
Journal:  Cancer Sci       Date:  2017-10-12       Impact factor: 6.716

8.  P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation.

Authors:  Xiaochen Xie; Xiaoguang Shi; Haixia Guan; Qiqiang Guo; Chenling Fan; Wenwu Dong; Guiling Wang; Feng Li; Zhongyan Shan; Liu Cao; Weiping Teng
Journal:  Oncotarget       Date:  2017-04-11

9.  Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.

Authors:  Astrid Grottke; Florian Ewald; Tobias Lange; Dominik Nörz; Christiane Herzberger; Johanna Bach; Nicole Grabinski; Lareen Gräser; Frank Höppner; Björn Nashan; Udo Schumacher; Manfred Jücker
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

10.  Ultrasound features of extranodal extension in the metastatic cervical lymph nodes of papillary thyroid cancer: a case-control study.

Authors:  Jiali Mu; Xiaofeng Liang; Fangxuan Li; Juntian Liu; Sheng Zhang; Jing Tian
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

View more
  6 in total

1.  MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.

Authors:  Stefana Stojanović; Zorana Dobrijević; Sonja Šelemetjev; Ilona Đorić; Jelena Janković Miljuš; Vladan Živaljević; Tijana Išić Denčić
Journal:  Endocrine       Date:  2022-09-14       Impact factor: 3.925

Review 2.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

3.  MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.

Authors:  Lei Dai; Weidong Zhang; Xianjiang Wu; Shuihong Zhou
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

Review 4.  E-cadherin on epithelial-mesenchymal transition in thyroid cancer.

Authors:  Xiaoyu Zhu; Xiaoping Wang; Yifei Gong; Junlin Deng
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

5.  LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.

Authors:  Ding Li; Ding Wang; Haofeng Liu; Xiaohui Jiang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancer.

Authors:  Qiliang Peng; Yi Shen; Peifeng Zhao; Shang Cai; Zhengyang Feng; Ming Cheng; Yongyou Wu; Yaqun Zhu
Journal:  BMC Cancer       Date:  2020-10-15       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.